Study: Marijuana Use Associated With Decreased Incidence of Liver Cirrhosis in Those With Hepatitis C

Marijuana use is associated with decreased incidence of liver cirrhosis in those with the Hepatitis C Virus, according to a new study published by the Canadian Journal of Gastroenterology and Hepatology.

A cirrhosis word cloud.

“The effect of cannabis use on chronic liver disease (CLD) from Hepatitis C Virus (HCV) infection, the most common cause of CLD, has been controversial”, states the study’s abstract. “Here, we investigated the impact of cannabis use on the prevalence of CLD among HCV infected individuals.”

For the study researchers “analyzed hospital discharge records of adults (age ≥ 18 years) with a positive HCV diagnosis”, evaluating “records from 2007 to 2014 of the Nationwide Inpatient Sample (NIS)” while excluding “records with other causes of chronic liver diseases (alcohol, hemochromatosis, NAFLD, PBC, HBV, etc.).”

Read moreStudy: Marijuana Use Associated With Decreased Incidence of Liver Cirrhosis in Those With Hepatitis C

Nebraska Judiciary Committee Votes to Legalize Medical Marijuana

Nebraska’s Judiciary Committee has passed legislation to legalize medical marijuana.

Legislative Bill 622 was passed by the Judiciary Committee with a 6 to 1 vote, with Senator Stebe Halloran casting the sole “No” vote. The measure allows those with a qualifying condition to possess and use marijuana medicines if they receive a recommendation from a physician and become licensed with the state. A system of regulated marijuana dispensaries would be authorized.

Qualifying conditions would include opioid addiction, AIDS, epilepsy, glaucoma, Crohn’s disease, Tourette’s syndrome, hepatitis C, lupus, Parkinson’s disease, Lyme disease, spinal cord injury or disease, post traumatic stress disorder (PTSD) and anxiety.

Read moreNebraska Judiciary Committee Votes to Legalize Medical Marijuana